PATENT CLAIM ANALYSIS

Application Number: 16079880
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "309000"]

Abstract:
Provided in the present invention are a substituted heteroaryl compound, a composition containing same, and an application thereof, the present invention disclosing a heteroaryl compound of the formula (I), or a crystalline form, a pharmaceutically acceptable salt, a prodrug, a stereoisomer, a hydrate, or a solvent compound thereof. The substituted heteroaryl compound and the composition containing same set forth in the present invention can be used for regulating hypoxia inducible factor (HIF) and/or endogenous erythropoietin (EPO), simultaneously having better pharmacokinetic parameter characteristics and being able to improve the drug concentration of the compound in animal bodies, in order to improve the curative effect and safety of the drug.

Claim (Index 15):
The compound according to  claim 11  or a pharmaceutically acceptable salt thereof, wherein R 1  and R 2  are deuterium.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 96.0
- Lexical Diversity: 1.84058
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15561471', '15561435', '12866023', '15561464', '12734895']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8031111167268826
- 35 USC 102 Novelty (BERT): 0.511523100604134
- Combined Prediction Score: 0.7739523151146078
- Mean Citation Score: 282.9175
- Max Citation Score: 287.5176
- Similarity Product: 208.79270607032777

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test